[1] VALDEZ IA,DIRICE E,GUPTA M,et al.Proinflammatory cytokines induce endocrine differentiation in pancreatic ductal cells via STAT3-dependent NGN3 activation[J].Cell Rep,2016,15(3):460. doi: 10.1016/j.celrep.2016.03.036
[2] VELAYOS T,MARTÍNEZ R,ALONSO M,et al.An activating mutation in STAT3 results in neonatal diabetes through reduced insulin synthesis[J].Diabetes,2017,66(4):1022. doi: 10.2337/db16-0867
[3] SAARIMÄKI-VIRE J,BALBOA D,RUSSELL MA,et al.An activating STAT3 mutation causes neonatal diabetes through premature induction of pancreatic differentiation[J].Cell Rep,2017,19(2):281.
[4] 侯清涛,李芸,李舍予,等.全球糖尿病疾病负担现状[J].中国糖尿病杂志,2016,24(1):92. doi: 10.3969/j.issn.1006-6187.2016.01.023
[5] 李凤萍,杨孟雪,李显文,等.2型糖尿病大血管病变患者血清诱导的人脐静脉内皮细胞中JAK2/STAT3信号通路的表达[J].第二军医大学学报,2016,37(4):452.
[6] 李迎新,洪郁芝.SOCS-3在胰岛素抵抗中的作用机制及研究进展[J].中国现代医生,2016,54(36):163.
[7] VASAMSETTI SB,KARNEWAR S,KANUGULA AK,et al.Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation:Potential role in atherosclerosis[J].Diabetes,2015,64(6):2028. doi: 10.2337/db14-1225
[8] 谈艳,薛雨平,陈文鹤,等.运动、膳食干预对肥胖大鼠胰岛素抵抗作用机制的研究[J].中国运动医学杂志,2014,33(8):797. doi: 10.3969/j.issn.1000-6710.2014.08.008
[9] PEDROSO JA,BUONFIGLIO DC,CARDINALI LI,et al.Inactivation of SOCS3 in leptin receptor-expressing cells protects mice from diet-induced insulin resistance but does not prevent obesity[J].Mol Metab,2014,3(6):608. doi: 10.1016/j.molmet.2014.06.001
[10] WANG C,DAI J,YANG M,et al.Silencing of FGF-21 expression promotes hepatic gluconeogenesis and glycogenolysis by regulation of the STAT3-SOCS3 signal[J].FEBS J,2014,281(9):2136. doi: 10.1111/febs.12767
[11] MA C,YU H,XIAO Y,et al.Momordica charantia extracts ameliorate insulin resistance by regulating the expression of SOCS-3 and JNK in type 2 diabetes mellitus rats[J].Pharm Biol,2017,55(1):2170.
[12] ZHOU X,LIU W,GU M,et al.Helicobacter pylori infection causes hepatic insulin resistance by the c-Jun/miR-203/SOCS3 signaling pathway[J].J Gastroenterol,2015,50(10):1027. doi: 10.1007/s00535-015-1051-6
[13] SAID E,ZAITONE SA,ELDOSOKY M,et al.Nifuroxazide,a STAT3 inhibitor,mitigates inflammatory burden and protects against diabetes-induced nephropathy in rats[J].Chem Biol Interact,2017,281(1):111.
[14] WANG H,XING W,TANG S,et al.HuoXueJieDu formula alleviates diabetic retinopathy in rats by inhibiting SOCS3-STAT3 and TIMP1-A2M pathways[J].Int J Genomics,2017,2017(3):1.
[15] DUMPATI R,DULAPALLI R,KONDAGARI B,et al.Suppressor of cytokine signaling-3 as a drug target for type 2 diabetes mellitus:A structure-guided approach[J].ChemistrySelect,2016,1(10):2502. doi: 10.1002/slct.201600640
[16] 张旭,陈俊国,吴鸣,等.细胞因子信号转导抑制因子3对糖尿病大鼠胰岛素受体底物1及其丝氨酸磷酸化水平的影响[J].中华全科医学,2016,14(7):1095.
[17] MAHONY R,AHMED S,DISKIN C,et al.SOCS3 revisited:A broad regulator of disease,now ready for therapeutic use?[J].Cell Mol Life Sci,2016,73(17):1.
[18] REDA E,HASSANEEN S,EL-ABHAR HS.Novel trajectories of bromocriptine antidiabetic action:Leptin-IL-6/JAK2/p-STAT3/SOCS3,p-IR/p-AKT/GLUT4,PPAR-γ/adiponectin,Nrf2/PARP-1,and GLP-1[J].Front Pharmacol,2018,9(1):771.
[19] BLUYSSEN HA,RASTMANESH MM,TILBURGS C,et al.IFNγ-dependent SOCS3 expression inhibits IL-6-induced STAT3 phosphorylation and differentially affects IL-6 mediated transcriptional responses in endothelial cells[J].Am J Physiol Cell Physiol,2010,299(2):C354.
[20] 张旭,陈俊国,章爱莲,等.慢病毒介导细胞因子信号转导抑制因子3基因沉默对糖尿病大鼠胰岛素信号通路的影响[J].中华糖尿病杂志,2017,9(12):779. doi: 10.3760/cma.j.issn.1674-5809.2017.12.010